Drug Shortage Report for HEPARIN SODIUM INJECTION, USP
Report ID | 154482 |
Drug Identification Number | 02264307 |
Brand name | HEPARIN SODIUM INJECTION, USP |
Common or Proper name | Heparin Sodium Injection, USP 10 000 USP units/mL MD Vial 1 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | HEPARIN SODIUM |
Strength(s) | 10000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
Packaging size | 1mL |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-02-01 |
Estimated end date | 2023-02-21 |
Actual end date | 2023-02-15 |
Shortage status | Resolved |
Updated date | 2023-02-24 |
Company comments | On backorder effective September 1, 2022 until February 21, 2023 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2023-02-24 | French | Compare |
v17 | 2023-02-24 | English | Compare |
v16 | 2023-01-16 | French | Compare |
v15 | 2023-01-16 | English | Compare |
v14 | 2022-12-15 | French | Compare |
v13 | 2022-12-15 | English | Compare |
v12 | 2022-11-02 | French | Compare |
v11 | 2022-11-02 | English | Compare |
v10 | 2022-08-21 | French | Compare |
v9 | 2022-08-21 | English | Compare |
v8 | 2022-08-08 | French | Compare |
v7 | 2022-08-08 | English | Compare |
v6 | 2022-07-07 | French | Compare |
v5 | 2022-07-07 | English | Compare |
v4 | 2022-06-01 | French | Compare |
v3 | 2022-06-01 | English | Compare |
v2 | 2022-02-08 | French | Compare |
v1 | 2022-02-08 | English | Compare |
Showing 1 to 18 of 18